Your full-stack
RNA partner

Quantoom Biosciences is a full-stack RNA partner for mRNA- and saRNA-based vaccines and therapeutics. Its N-Force toolbox relies on 3 core elements to turn any antigen into a formulated (sa)mRNA drug product: Ncode for sequence design and optimization, Ntensify® for RNA production and Ncapsulate® for RNA formulation.

Beyond technology, Quantoom Biosciences assists its partners by providing extensive enabling solutions, ranging from strategic R&D partnerships to sequence design & optimization.

Laboratory technician operating the Ntensify midi, part of the Ntensify product line showing how we are reinventing the mRNA production

Your RNA manufacturing partner

Quantoom is on a mission to reinvent RNA technologies to enable the rapid development of (sa)mRNA as a drug-modality for life-changing RNA-based medicines reaching more patients worldwide, making the synthetic biology revolution a reality.​

While others think about 10%, we aim for >10x improvement that can completely transform the production of life-changing (sa)mRNA drugs.​

Quantoom is your full-stack RNA partner, dedicated to accelerating and de-risking your RNA drug development journey. By minimizing scale-up, time, and cost uncertainties — and maximizing your chances of success — our transformative N-Force toolbox empowers you from design to delivery.

Find out more about us

Trusted by

Logo CNC - Center for Neuroscience and Cell Biology
Logo of University of Berkeley in California, USA
Logo of the Pirbright Institute
Logo VaxThera
Logo Oxford cancer

N-Force toolbox

A powerful toolbox of technologies, to fast track your RNA development from design to delivery

Our toolbox of technologies provides our partners with a comprehensive set of solutions to enable RNA adoption, starting from a simple antigen sequence. It provides solution for molecular design, RNA production and formulation as well as support in derisking studies in-vitro and in-vivo.

Ncode logo white

RNA design

Bioinformatics platform

Ncode, RNA design platform

RNA design platform, from amino acid sequence to optimally functional RNA

Discover our track record
Logo Ntensify

RNA production

through redesigned and optimized (sa)mRNA process

Ntensify mRNA production systems

A (sa)mRNA production platform that is construct agnostic. It includes a process, mixes of reagents, disposables and scalable equipment from R&D to large scale commercial production

Discover our product line
Ncapsulate logo white

RNA chemistry

through new formulated delivery chemistry and optimized process

RNA Formulation Delivery - part of our full-stack mRNA partner offer

FTO delivery chemistries at the base of (sa)mRNA formulations and process for many applications (Prophylactic vaccines, cancer vaccines, therapeutics, etc.) 

Discover our offering

Track Record

Our N-Force toolbox has demonstrated performances in numerous pre-clinical and target-species evaluation

Swipe horizontally to explore →

Animal health
RNA
LLP
Sequence design & optimization
RNA/formulation preparation
In vitro testing
POC in target species
Early-phase development
Partners
sa/mRNA
QCX-002
Ncode
PPRV
CVIM The Pirbright Institute
saRNA
QCX-002
Ncode
Avian Influenza, HPAI
VaxThera
mRNA
QCX-002
Ncode
Feline cancer
Feline cancer
Undisclosed partner
mRNA
QCX-002
Ncode
Inf. disease
Undisclosed partner

Swipe horizontally to explore →

Cancer vaccines
RNA
LLP
Sequence design & optimization
RNA/formulation preparation
In vitro testing
Preclinical
Clinical
Partners
mRNA
QCX-002
Ncode
Melanoma (shared antigen)
Serum Institute of India
mRNA
QCX-002
Ncode
Melanoma (neoantigen)
Arizona State University
mRNA
QCX-002
Ncode
Colorectal (neoantigen)
Oxford Cancer
mRNA
QCX-002
Ncode
CAR-T
Undisclosed partner

Swipe horizontally to explore →

Prophylactic vaccines
RNA
LLP
Sequence design & optimization
RNA/formulation preparation
In vitro testing
Preclinical
Clinical
Partners
mRNA
REF LLP
Ncode
Rabies
Internal program
mRNA
REF LLP
Ncode
COVID-19 & Influenza
Horizon Europe
saRNA
QCX-002
Ncode
Influenza H5N1
Serum Institute of India
mRNA
REF LLP
Ncode
Malaria
European Vaccine Initiative

Explore further

Ressources which demonstrate how we are reinventing mRNA production

Resources

News and press releases which demonstrate how we are reinventing mRNA production

News

Discover how we are reinventing mRNA production by visiting our Ntensify midi virtual showroom

Virtual showroom

CAUGCAUGGCUAACGUAGCUAGCAUGCUAACGUAGCUAGCAUGC
UACGUAGCUAGCAUGCUAACGUAGCUAGGCUAACGUACGUAGCU

How to design a plasmid

Download our general plasmid design guidelines for the Ntensify® process.